As for gastric cancer, most patients are infected with H. pylori and have severe active gastritis or atrophic gastritis, suggesting that candidate carcinogens metabolized by CYP2C19 require severe inflammation or atrophic changes induced by H. pylori infection in order to initiate cancerous transformation in gastric epithelial cells [18]. Here, CYP2C19 is linked to chronic atrophic gastritis.